125 related articles for article (PubMed ID: 10334368)
1. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma.
Danias J; Podos SM
Am J Ophthalmol; 1999 May; 127(5):623-5. PubMed ID: 10334368
[No Abstract] [Full Text] [Related]
2. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma.
Leske MC; Hyman L; Hussein M; Heijl A; Bengtsson B
Am J Ophthalmol; 1999 May; 127(5):625-6. PubMed ID: 10334369
[No Abstract] [Full Text] [Related]
3. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.
Am J Ophthalmol; 1998 Oct; 126(4):487-97. PubMed ID: 9780093
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.
Am J Ophthalmol; 1998 Oct; 126(4):498-505. PubMed ID: 9780094
[TBL] [Abstract][Full Text] [Related]
5. Brinzolamide--a new topical carbonic anhydrase inhibitor for glaucoma.
Med Lett Drugs Ther; 1998 Sep; 40(1036):95-6. PubMed ID: 9774966
[No Abstract] [Full Text] [Related]
6. GLAUCOMA TREATED WITH DARANIDE A CLINICAL TRIAL.
Luntz MH
Br J Ophthalmol; 1961 Feb; 45(2):125-9. PubMed ID: 18170651
[No Abstract] [Full Text] [Related]
7. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
[TBL] [Abstract][Full Text] [Related]
8. Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma.
Schmidt KG; von Rückmann A; Pillunat LE
Br J Ophthalmol; 1998 Jul; 82(7):758-62. PubMed ID: 9924367
[TBL] [Abstract][Full Text] [Related]
9. European Glaucoma Prevention Study.
Quigley HA
Ophthalmology; 2005 Sep; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
[No Abstract] [Full Text] [Related]
10. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
Gafencu O; Armegioiu M; Ionita M
Oftalmologia; 1997; 41(1):66-8. PubMed ID: 9138500
[TBL] [Abstract][Full Text] [Related]
11. [Use of Diacarb to attain hypotension in preoperative treatment of patients with different cataract etiology].
Alekseev BN; Iurova OV
Vestn Oftalmol; 1997; 113(5):8-10. PubMed ID: 9508754
[TBL] [Abstract][Full Text] [Related]
12. Surgical vs medical management of chronic open-angle glaucoma.
Stewart WC; Sine CS; LoPresto C
Am J Ophthalmol; 1996 Dec; 122(6):767-74. PubMed ID: 8956630
[TBL] [Abstract][Full Text] [Related]
13. Consultation Section: Glaucoma. Glaucoma surgical problem revisited: July consultation #1.
Samuelson TW
J Cataract Refract Surg; 2019 Jul; 45(7):1047. PubMed ID: 31262465
[No Abstract] [Full Text] [Related]
14. Low-tension glaucoma.
Alexander LJ; Fingeret M; Jennings B; Thimons JJ
Optom Clin; 1991; 1(1):255-65. PubMed ID: 1686844
[No Abstract] [Full Text] [Related]
15. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
March WF; Ochsner KI
Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
[TBL] [Abstract][Full Text] [Related]
16. Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy.
Siesky B; Harris A; Kagemann L; Stefansson E; McCranor L; Miller B; Bwatwa J; Regev G; Ehrlich R
Acta Ophthalmol; 2010 Feb; 88(1):142-9. PubMed ID: 19706018
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
[TBL] [Abstract][Full Text] [Related]
18. Switching from dorzolamide to brinzolamide: effect on intraocular pressure and patient comfort.
Inoue K; Wada SA; Wakakura M; Inoue J; Tomita G
Jpn J Ophthalmol; 2006; 50(1):68-9. PubMed ID: 16453193
[No Abstract] [Full Text] [Related]
19. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?
Juncal VR; Abdo Jorge F; Paranhos A; Santos Prata T
Can J Ophthalmol; 2015 Aug; 50(4):297-301. PubMed ID: 26257224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
